블로그

기타 건강 상태

Toxic Epidermal Necrolysis (TEN): Causes, Symptoms, Treatment, and Survival Rate

Doctor consulting with patient about Toxic Epidermal Necrolysis

Toxic epidermal necrolysis (TEN) is a rare, life-threatening skin reaction. It is most commonly triggered by certain medications. However, in rare cases, it can be caused by infections or vaccinations. 

공제금 지원에 대해 전문가와 상담하세요

상담 일정을 잡으세요

A severe form of Steven-Johnson’s syndrome (SJS), TEN is diagnosed when you have large areas of blistering and peeling skin on more than 30% of your body. TEN also causes extensive damage to the moist linings (mucous membranes) in the mouth, nose, throat, eyes, and genitals.
In SJS, you have small areas of peeling skin, affecting less than 10% of your body. SJS-TEN overlap disease is when 10% to 30% of the body is affected.  

How Common Is Toxic Epidermal Necrolysis?

TEN is a rare condition, affecting 1.9 people per million U.S. adults each year [1]. 

What Causes Toxic Epidermal Necrolysis?

In some cases, the exact cause is not known. In others, several factors can induce TEN, including:

  • Antiseizure medications: Phenobarbital, phenytoin, carbamazepine, valproic acid, and lamotrigine
  • Antibacterial drugs: Sulfonamides (trimethoprim-sulfamethoxazole), chloramphenicol, penicillins, and ciprofloxacin
  • Non-steroidal anti-inflammatory drugs (NSAIDs): Piroxicam, meloxicam
  • Antigout agents: Allopurinol
  • Anti-HIV medications: Nevirapine and abacavir

Rare triggers can include:

  • 세균 감염: Mycoplasma pneumoniae infections
  • 바이러스 감염: Herpes and hepatitis A
  • Vaccines: Meningococcal B and MMR vaccines 
  • 이식편대숙주병  

Risk Factors

The following factors can increase your risk of TEN:

  • HIV infection 
  • Weak immune system (such as in HIV/AIDS and autoimmune disorders)
  • Personal or family history of TEN
  • Genetic factors
  • Cancer (specifically blood cancers)

증상

Mature woman suffering body aches from Toxic Epidermal NecrolysisSymptoms may appear a few weeks after you start taking a drug. Initially, you may have flu-like symptoms, such as:

  • 몸살
  • 기침 
  • 발열 
  • 오한
  • 두통
  • Red and swollen eyes

As the disease progresses, you may have:

  • Widespread skin pain
  • A rapidly spreading rash affecting more than 30% of your body
  • Blisters and peeling skin 
  • Sores and swelling on the mucous membranes, including the mouth, eyes, respiratory tract, and genitals

These signs and symptoms may resemble other skin diseases. Because TEN is life-threatening, seek immediate medical care if you think you have symptoms of TEN. 

Toxic Epidermal Necrolysis Treatment

People with TEN need emergency care at a hospital, preferably in an intensive care unit (ICU) or burn center. Treatment is mainly supportive and includes [2]:

  • Stopping all potential triggers
  • Isolation to prevent infection
  • Administering IV fluids and nutrition
  • Protective dressings and antibacterial creams or ointments to prevent skin infection
  • Antibiotic therapy if signs of infection are present
  • Medications to reduce pain
  • Eye and oral cavity examination 
  • Oxygen via a face mask (if needed)
  • Medications to prevent blood clots

No specific treatment for TEN exists. However, your provider may consider the following based on your age, symptom severity, expectations, and preferences:

정맥 주사 면역글로불린(IVIG)

IVIG is a sterile liquid that contains disease-fighting proteins (면역글로불린 or antibodies). Some studies show that early treatment with high-dose IVIG can improve survival and speed recovery [3].

Systemic steroids

Your provider may give you a steroid to halt the progression of TEN. Nonetheless, the use of steroids is highly controversial. Some studies suggest that steroids may increase the risk of death. 

IVIG With Steroids

According to a recent review published in the Journal of the American Academy of Dermatology, clinicians should consider combination therapy with IVIG and steroids to treat TEN [4]. The authors of the review conclude that this combination may reduce death risk in individuals with TEN. 

Plasmapheresis (Plasma Exchange)

Plasmapheresis separates the liquid part of the blood (plasma) from blood cells. Following separation, the blood cells are mixed with a liquid and infused back into the body. 
Daily plasmapheresis for 3 days can help remove the causative drug, its byproducts, and other inflammatory substances from the body. 

Tumor Necrosis Factor-Alpha (TNF-Alpha) Inhibitors

TNF-alpha inhibitors, such as infliximab and etanercept, may help resolve skin lesions in toxic epidermal necrolysis. They may be used alone or as a second-line medication.  

IVIG가 도움이 될까요? | 무료 IVIG 치료 정보

(877) 778-0318

 

Toxic Epidermal Necrolysis Survival Rate

Toxic epidermal necrolysis causes death in about 25% of the cases, and the death rate is lower in children (less than 10%). The death rate is higher if you [5, 6]:

  • Are over 40 
  • Have high blood sugar
  • Have a fast heart rate
  • Have chronic kidney disease

 

합병증

People older than 70 years are most likely to develop complications. Likewise, the risk of complications is higher in people with liver cirrhosis (scarring of the liver) or cancer. 
Complications of TEN include:

부패

Sepsis or blood infection is a life-threatening condition. It happens when the immune response to an infection damages your body’s vital organs, putting you into shock and causing organ failure. 

Breathing Problems

If your lungs are involved, you may find it difficult to breathe. In severe cases, your lungs may be too weak, causing an excess of carbon dioxide and a deficiency of oxygen in your blood. 

Eye Problems

Eye problems associated with TEN are dry eye, ingrown eyelashes, corneal scarring, and, in rare cases, blindness.
 

Toxic Epidermal Necrolysis Long-Term Effects

Some long-term effects among TEN survivors are:

  • Dry itchy skin
  • Hair or nail loss
  • Excessive sweating
  • 건조한 눈
  • Sensitivity to light 
  • 입이 마르다
  • Lung damage

In a recent survey of 121 TEN/SJS survivors, more than half screened positive for depression, and over 40% screened positive for anxiety [7].
 

재정 지원 받기

상담 일정을 잡으세요

 

Toxic Epidermal Necrolysis (TEN) vs Steven-Johnson’s Syndrome (SJS)

The major differences between TEN and SJS are as follows:

Features

TEN

SJS

Severity

More severe

Less severe

Affected body surface

More than 30%

Less than 10%

Occurrence in the US

1.9 per million people each year

9.3 per million people each year

Death rate

About 25% in adults

About 10%

 

자주 묻는 질문

Which drug causes toxic epidermal necrolysis?

Medications commonly associated with toxic epidermal necrolysis are:

  • Antiseizure medications: Phenobarbital, phenytoin, carbamazepine, valproic acid, and lamotrigine
  • Antibacterial drugs: Sulfonamides (trimethoprim-sulfamethoxazole), chloramphenicol,  penicillins, and ciprofloxacin

What causes epidermal necrolysis?

Medications are the primary causes of TEN in adults, whereas infections are the main causes in children.  

Which layer of skin is affected by toxic epidermal necrolysis?

Toxic epidermal necrolysis causes the top layer of your skin (epidermis) to detach from the lower layers of skin (dermis). 

What are the clinical features of toxic epidermal necrolysis?

TEN causes peeling skin on more than 30% of your body. It also causes extensive damage to the moist linings (mucous membranes) in the mouth, nose, throat, eyes, and genitals.
 

참고문헌:

  1. Labib A, Milroy C. Toxic Epidermal Necrolysis. [Updated 2023 May 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK574530/# 
  2. Seminario-Vidal, Lucia et al. “Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults.” Journal of the American Academy of Dermatology vol. 82,6 (2020): 1553-1567. doi:10.1016/j.jaad.2020.02.066 
  3. Momin, Saira B. “Review of intravenous immunoglobulin in the treatment of stevens-johnson syndrome and toxic epidermal necrolysis.” The Journal of clinical and aesthetic dermatology vol. 2,2 (2009): 51-8.
  4. Tsai, Tsung-Yu et al. “Treating toxic epidermal necrolysis with systemic immunomodulating therapies: A systematic review and network meta-analysis.” Journal of the American Academy of Dermatology vol. 84,2 (2021): 390-397. doi:10.1016/j.jaad.2020.08.122 
  5. Benedetti, Julia. “Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN).” MSD Manual Consumer Version, 16 Feb. 2024, www.msdmanuals.com/home/skin-disorders/hypersensitivity-and-reactive-skin-disorders/stevens-johnson-syndrome-sjs-and-toxic-epidermal-necrolysis-ten.
  6. Wasuwanich, Paul et al. “Epidemiology of Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States and factors predictive of outcome.” JAAD international vol. 13 17-25. 11 Jul. 2023, doi:10.1016/j.jdin.2023.06.014 
  7. Hoffman, Melissa et al. “Long-term Physical and Psychological Outcomes of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.” JAMA dermatology vol. 157,6 (2021): 712-715. doi:10.1001/jamadermatol.2021.1136
이 정보는 의학적 조언이나 치료를 대체할 수 없습니다. 새로운 치료를 시작하기 전에 담당 의사 또는 의료 서비스 제공자와 건강 상태에 대해 상담하십시오. AmeriPharma® Specialty Care는 제공된 정보 또는 그 결과로 내려진 진단이나 치료에 대해 어떠한 책임도 지지 않으며, 콘텐츠의 신뢰성에 대해서도 책임을 지지 않습니다. AmeriPharma® Specialty Care는 여기에 나열된 모든 웹사이트/기관을 운영하는 것은 아니며, 해당 콘텐츠의 가용성이나 신뢰성에 대해서도 책임을 지지 않습니다. 이러한 목록은 AmeriPharma® Specialty Care의 보증, 후원 또는 추천을 암시하거나 구성하지 않습니다. 이 웹페이지에는 AmeriPharma® Specialty Care와 제휴하지 않은 제약 회사의 상표 또는 등록 상표인 브랜드 처방약에 대한 참조가 포함될 수 있습니다.
의학적으로 검토됨 Samantha Kaeberlein 박사, 약학박사

사만다 케버리인 약학박사는 오하이오주 캔턴에서 태어나고 자랐습니다. 2020년 노스이스트 오하이오 의과대학(NEOMED)에서 약학 학위를 받았습니다. 그녀의 직업에서 가장 보람 있는 부분은 환자들이 자신의 건강 관리에 대해 정보에 기반하고 균형 잡힌 결정을 내릴 수 있도록 의료 지침을 제공하는 것입니다. 그녀의 전문 분야는 노인 의학 및 장기 요양입니다. 여가 시간에는 야외 활동, 독서, 그리고 미국 최고의 커피를 찾는 것을 즐깁니다.

문의하기

아래 HIPAA 규격 양식을 사용하여 처방전 재조제를 요청하세요. 복용 중인 약이나 복용 방법에 대한 문의 사항이 있으시면 문의하기 페이지를 방문하시거나 다음 번호로 전화해 주세요. (877) 778-0318.

HIPAA Compliant

제출하면 AmeriPharma에 동의하는 것입니다. 이용 약관, 개인정보 보호정책, 그리고 개인정보 보호 관행 고지

ko_KRKorean